Bolt Biotherapeutics, Inc. (BOLT) Social Stream
BOLT BIOTHERAPEUTICS INC (BOLT) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering BOLT.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-08-16 | 4 | $45 | $35 | $39.75 | $1.71 | 2224.56% |
| 2021-11-10 | 4 | $45 | $33 | $38.5 | $1.71 | 2151.46% |
| 2021-12-06 | 4 | $45 | $19 | $34.75 | $1.71 | 1932.16% |
| 2022-01-06 | 4 | $42 | $11 | $26.25 | $1.71 | 1435.09% |
| 2022-02-01 | 2 | $33 | $7 | $19.666 | $1.71 | 1050.06% |
| 2022-04-12 | 3 | $33 | $7 | $18.666 | $1.71 | 991.58% |
| 2022-05-03 | 3 | $16 | $7 | $10.333 | $1.71 | 504.27% |
| 2022-08-01 | 3 | $13 | $5 | $8.666 | $1.71 | 406.78% |
| 2022-09-06 | 3 | $7 | $4 | $5.333 | $1.71 | 211.87% |
| 2022-11-23 | 4 | $8 | $4 | $6 | $1.71 | 250.88% |
| 2023-04-03 | 4 | $8 | $3 | $5.5 | $1.71 | 221.64% |
| 2023-05-15 | 4 | $8 | $3.001 | $5.5 | $1.71 | 221.64% |
| 2023-05-23 | 4 | $8 | $3 | $5.5 | $1.71 | 221.64% |
The Trend in the Analyst Price Target
Over the past 22 months, BOLT's average price target has gone down $34.
Over the past 45 weeks, BOLT's average upside potential has been 248.87%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2022-08-01 | 3 | 13 | 5.000 | 8.666 | 2.17 | 299.35% |
| 2022-11-23 | 4 | 8 | 4.000 | 6.000 | 1.32 | 354.55% |
| 2023-03-31 | 4 | 8 | 3.000 | 5.500 | 1.39 | 295.68% |
| 2023-05-12 | 4 | 8 | 3.000 | 5.500 | 1.80 | 205.56% |
| 2023-05-15 | 4 | 8 | 3.001 | 5.500 | 1.95 | 182.05% |
BOLT Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1.5 | 3 | 0 | 1 | 0 | 0 | 4 |
The Trend in the Broker Recommendations
Over the past 16 months, BOLT's average broker recommendation rating improved by 0.
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- In the context of all US stocks, BOLT BIOTHERAPEUTICS INC's upside potential (average analyst target price relative to current price) is higher than 1679.31% of them.
- In the context of all US stocks, BOLT BIOTHERAPEUTICS INC's number of analysts covering the stock is greater than 205.47% of them.
- In the context of stocks in the small market cap category, BOLT BIOTHERAPEUTICS INC's variance in analysts' estimates is lower than -1281.66% of them.
- BOLT has a greater average analyst price target than 753.71% of stocks in the small market cap category.
In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to BOLT BIOTHERAPEUTICS INC are LABP, TERN, and SNSE.
View All Top Stocks by Price Target
Is BOLT a Buy, Hold or Sell? See the POWR Ratings now!